Navigation Links
Monitect Multiple Drug Screen Cassette Test

ProductsMonitect Multiple Drug Screen Cassette Test
Company Branan Medical Corp.
Item Monitect Multiple Drug Screen Cassette Test
  • Simultaneous detection of multiple drugs and adulterants
  • User friendly, reliable, accurate
  • Simple interpretation
  • 1-step qualitative assay
  • Room temperature storage
  • Multiple test configurations
Description Simply collect sample, pipette into testing wells and read results. Monitect is a FDA 510K cleared multiple drug screen cassette that can simultaneously test for both drugs and adulterants. It can test from one (1) to five (5) drugs and can be accompanied with four (4) adulterant tests.
Info Branan Medical Corp.
Customer Service: 866 intect7
Web site:

Related medicine products :

1. Acclaim 7000 Multiple Application Laser
2. ALLPORT Multiple Clip Applier
3. LIGACLIP ERCA Endoscopic Rotating Multiple Clip Applier
4. ACUCLIP Right-Angle (Multiple Clip Applier With Titanium Clips)
5. ENDO CLIP MultApplier (Multiple Use Clip Applier)
6. LIGACLIP 20/20 Reloadable Multiple Clip Applier
7. LIGACLIP MCA Multiple Clip Applier
8. LIGACLIP ALLPORT/ALLPORT LS Endoscopic Rotating Multiple Clip Applier
9. LIGACLIP ERCA Endoscopic Rotating Multiple Clip and Applier
10. Mx4000 Multiplex Quantitative PCR System
11. DLP® Multiple Perfusion Sets
Aplio was designed for intuitive operation so you can get the results you are looking for quickly and easily. From customizable measurement packages to an ergonomic platform design, Aplio was built m...
This catheter is intended for ultrasound examination of coronary intravascular pathology ONLY. Intravascular ultrasound imaging is indicated in patients who are candidates for transluminal coronary i...
Fludeoxyglucose F 18 Injection:, The PETNET SafetyNET: 99% On-Time Delivery of MetaTrace FDG , Largest Cyclotron - Equipped Radiopharmacy Network , 39 MetaTrace FDG producing sites , Customi...
... The AB Holter, a full ... provides sophisticated,ambulatory ECG analysis and ... environment.,Designed to use Windows 2000,XP ... system allows,the option of employing,Advanced ...
Medicine Products:
(Date:12/1/2015)... ... December 01, 2015 , ... For many X-rays taken ... for accurate interpretation by the radiologist. The marking utensils are so small, however, ... has found a way to alleviate this problem. , He developed the patent-pending ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates ... a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they ... Society of North America (RSNA) 2015 annual meeting through December 3 in Chicago, ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, announced ... the United States. Clarity is a Superior Dual Wavelength Platform which combines two ... platform that is easy to own and operate. , For over a decade, ...
(Date:12/1/2015)... ... December 01, 2015 , ... PYA’s ... Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning healthcare ... once a deal is signed. This quick-read guidance suggests that failing to ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
(Date:12/1/2015)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... that the company will present at the LD Micro Main ... Luxe Sunset Boulevard Hotel in Los Angeles, CA. ... will present on Thursday, December 3, at 9:00 am Pacific ... register at least 10 minutes prior to the start of ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology: